Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
04/2004
04/01/2004US20040063713 Such as 2-((4-(2-fluorophenyl)-1-piperazinyl)methyl)-1H-thieno(3,4-d)imidazole
04/01/2004US20040063694 2-ethyl-10-(4-methyl-1-piperazinyl)-4H-thieno(2,3-b)(1,5) benzodiazepine; antipsychotic; does not elevate cholesterol levels
04/01/2004US20040063673 Specific MMP-13 enzyme inhibitors; tissue breakdown diseases
04/01/2004US20040063222 Method of assaying pyrrole-containing biological compounds
04/01/2004CA2496500A1 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
03/2004
03/31/2004EP1401840A1 Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines
03/31/2004EP1401838A2 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
03/31/2004EP1401830A2 Quinazolinediones as antibacterial agents
03/31/2004EP1401825A2 Thiophene derivatives as antiviral agents for flavivirus infection
03/31/2004EP1401453A2 Protease inhibitors
03/31/2004EP1401441A2 Allosteric adenosine receptor modulators
03/31/2004EP1401434A1 Modulators of peroxisome proliferator activated receptors (ppar)
03/31/2004CN1486316A Processes for the preparation of carbapenem-type antibacterial agents
03/31/2004CN1486312A Pyrazole compounds useful as protein kinase inhibitors
03/31/2004CN1486311A Pyrazole compounds useful as protein kinase inhibitors
03/31/2004CN1486310A Pyrazole compounds useful as protein kinase inhibitors
03/31/2004CN1486309A Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents)
03/30/2004US6713637 Reaction of the alkali salt of 3,4-dihydroxythiophene-2,5-dicarboxylic acid diester and epihalohydrin in polar solvent
03/30/2004US6713635 As chemical intermediates used for the preparation of s-alpha-ethyl-2-oxo-1-pyrrolidine acetamide
03/30/2004US6713634 Pyrroloazepine derivatives
03/30/2004US6713487 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition
03/30/2004US6713484 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
03/30/2004US6713477 1,4-benzthiazines or benzoxazines; matrix metalloproteinase inhibitors
03/30/2004US6713471 Such as tert-butyl-1-methyl-6,7,9,12-tetrahydro-5h-pyrido-(4,3-b)(1,4) thiazepino(2,3,4-hi)indole-11(10h)-carboxylate; serotonin agonists and antagonists; central nervous system disorders
03/30/2004CA2079706C Inhibitor of atherosclerotic intimal thickening
03/25/2004WO2004024081A2 Acetyl 2-hydroxy-1,3 diaminoalkanes
03/25/2004WO2004024065A2 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use
03/25/2004WO2003080624A3 Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases
03/25/2004WO2003022214A3 Piperazine and homopiperazine compounds
03/25/2004US20040058944 Osteoporosis; antiarthritic agents; antidiabetic agents
03/25/2004US20040058941 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
03/25/2004US20040058940 Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
03/25/2004US20040058933 Aryl carbamate derivatives, preperation and use thereof
03/25/2004US20040058930 Antiinflammatory agents; autoimmune disease
03/25/2004CA2498248A1 Acetyl 2-hydroxy-1,3 diaminoalkanes
03/25/2004CA2498106A1 Substituted bicyclic thiophene derivatives, compositions containing such compounds and methods of use
03/24/2004EP1400241A1 Fused cyclic compounds and medicinal use thereof
03/24/2004EP1399444A2 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
03/24/2004EP1399436A2 Oxytocin agonists
03/24/2004CN1142936C Condensed thienopyrimidines with phosphodiesterase-V inhibiting action, preparation process and use thereof
03/24/2004CN1142923C 12,13-modified epothilone derivatives
03/24/2004CN1142793C Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure
03/23/2004US6710055 Indole and benzimidazole antithrombotic compounds, such as 1-methyl-2-(n-amidinophenyl)-aminomethyl)-5-(n-(hydroxycarbo quinoline-8-sulfonylamino)-indole
03/18/2004WO2004022568A1 Aryl-ethanolamine derivatives as antiviral agents
03/18/2004WO2004022567A1 Heteroaryl-ethanolamine derivatives as antiviral agents
03/18/2004WO2004022566A1 4-OXO-4,7-DIHYDROTHIENO[2,3-b]PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS
03/18/2004WO2004022565A1 Multipurpose linker compounds and ligands and process for producing the same
03/18/2004WO2004022537A2 Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
03/18/2004US20040054187 Therapeutic ureas
03/18/2004US20040054183 Thienopyridine derivatives, their production and use
03/18/2004US20040054003 Pgd2 receptor antagonistic pharmaceutical compositions
03/18/2004US20040053957 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization
03/18/2004US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
03/18/2004US20040053217 Using conjugate agents comprise of photoreactive moiety to identify preferential micro and/or macromolecules in heterologous mixtures
03/17/2004EP1398317A1 Alicyclic compound for optical material
03/17/2004EP1397370A1 B-benzyloxyaspartate derivatives with amino group on benzene ring
03/17/2004CN1483035A Sulfamidothienopyrimidines
03/17/2004CN1142166C Syhnthesis of d-biotin
03/16/2004US6706878 Spiroazabicyclic heterocyclic compounds
03/16/2004US6706750 Useful in treating obesity and other disorders
03/16/2004US6706740 Controlling, prevention fungi infections
03/16/2004US6706707 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
03/11/2004WO2004020444A1 New 3,4-alkylenedioxythiophenedioxide compounds and polymers comprising monomeric units thereof
03/11/2004WO2004020443A1 Method for manufacturing crystalline form i of clopidogrel hydrogen sulphate
03/11/2004WO2004009578A3 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them
03/11/2004US20040049039 Treating neurodegenerative, psychotropic, and drug and alcohol induced central and peripheral nervous system disorders.
03/11/2004US20040048878 Heterocyclic compounds
03/11/2004US20040048867 Especially quinoline carbonyl pyrrolidines with binding selectivity to benzodiazepine site of GABAA receptor to treatanxiety, depression, a sleep disorder, or cognitive impairment.
03/11/2004US20040048864 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
03/11/2004US20040048854 From 4-amino-2-methyl-10H-thieno(2,3-b)(1,5) benzodiazpine HCl and 1-methylpiperazine in an aprotic high boiling solvent; purifying in an acid medium; basifying to pH of 7.5-9; and extracting with a low boiling organic solvent
03/11/2004US20040048853 Compounds, compositions, and methods
03/11/2004US20040048346 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds
03/11/2004CA2495823A1 Method for manufacturing crystalline form i of clopidogrel hydrogen sulphate
03/10/2004EP1395606A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
03/10/2004EP1395553A1 Pyrrolidine derivatives as factor xa inhibitors
03/10/2004EP1163244B1 Thienopyrimidine compounds, their production and use
03/10/2004CN1481243A Pharmaceutical formulation contg. thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
03/09/2004US6703502 Spiroazo bicyclic heterocyclic
03/09/2004US6703401 Compounds, their preparation and use
03/04/2004WO2004018480A1 6h-thieno`2, 3-b!pyrrole derivatives as antagonists of gonadotropin releasing hormone (gnrh)
03/04/2004WO2004018479A1 Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
03/04/2004WO2004018456A1 Two-photon absorption heteroaromatic chromophores and compositions thereof
03/04/2004WO2004018438A2 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
03/04/2004WO2004018428A1 Antibacterial benzoic acid derivatives
03/04/2004WO2004018081A1 Method of purifying biosubstance with electrolytically breakable affinity carrier, electrolytically breakable affinity carrier, kit for biosubstance purification and electrolytically breakable linker
03/04/2004WO2004018058A2 Compounds, compositions, and methods
03/04/2004WO2004017766A1 Novel nutraceutical compositions comprising biotin
03/04/2004WO2003082350A3 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
03/04/2004WO2003078646A3 Aza-thioxanthenones with antitumor activity
03/04/2004WO2002038540A9 Activity-dependent cysteine protease profiling reagent
03/04/2004US20040044201 Bone disorders; osteoporosis; oral diseases; antiarthritic agents
03/04/2004US20040044075 Alpha acyloxyacetamides for kallikrein and urokinase inhibition
03/04/2004US20040044030 Cardiovascular disorders; antiarrhythmia agents
03/04/2004US20040044029 Azabicyclic compounds are central nervous system active agents
03/04/2004US20040044011 2-Aminoalkyl-thieno[2,3-d]pyrimidines
03/04/2004CA2495050A1 Two-photon absorption heteroaromatic chromophores and compositions thereof
03/04/2004CA2494263A1 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
03/03/2004EP1394156A1 Chromene compound
03/03/2004EP1393747A1 Preventives/remedies for alzheimer's disease
03/03/2004EP1392698A1 Method for the production of 6-aryl-4h-s-triazolo[3,4-c]-thieno[2,3-e]-1,4-diazepines